Анемии в пожилом и старческом возрасте

Автор: Богданов А. Н., Волошин С. В.

Журнал: Вестник гематологии @bulletin-of-hematology

Статья в выпуске: 1 т.17, 2021 года.

Бесплатный доступ

Анемический синдром выявляется у 1/3 популяции. Гериатрические пациенты являются одной из основных групп риска развития анемии. Наиболее распространенными видами анемий у пациентов старших возрастных групп являются железодефицитные и В12дефицитные анемии, анемии хронических заболеваний, анемии при патологии почек и миелодиспластическом синдроме. Любая анемия приводит к снижению качества жизни, повышению заболеваемости и летальности и требует своевременной диагностики и лечения.

Анемии, частота в популяции, гериатрические пациенты, основные виды анемии, диагностика, лечение

Короткий адрес: https://sciup.org/170175044

IDR: 170175044

Список литературы Анемии в пожилом и старческом возрасте

Kassebaum N. J., Jasrasaria R., Naghavi M. et al. A systematic analysis of global anemia burden from 1990 to 2010 // Blood — 2014 — Vol. 123. — P. 615–624.
Chaparro C. M., Suchdev P. S. Anemia epidemiology, pathophysiology, and etiology in low- and middleincome countries // Ann. N Y Acad. Sci. — 2019 — Vol. 1450, N1. — P. 15–31.
Гериатрическая гематология. Заболевания системы крови в старших возрастных группах / Под ред. Л. Д. Гриншпун, А. В. Пивника. М.: Медиум, 2012, Т. 2. С. 407–452.
Stauder R, Valent P., Theurl I. Anemia at older age: etiologies, clinical implications, and management // Blood. — 2018 — Vol.131, N5. — P. 505–514.
Lanier J. B., Park J. J., Callahan R. C. Anemia in older adults // Am Fam Physician– 2018 –Vol. 98, N7. — P. 437–442.
Merchant A. A., Roy C. N. Not so benign haematology: anaemia of the elderly // Br. J. Haematol. — 2012– Vol. 156. № 2. — P. 173–185.
Ageing and health. WHO. 2018. http://www. who. int/mediacentre/factsheets/fs404/en/.
Blanc B., Finch C. A., Hallberg L. et al. Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser. 1968–Vol. 405. —P. 5–37.
Patel K. V., Longo D. L., Guralnik J. M. Hemoglobin concentration and the risk of death in older adults: differences by race/ethnicity in the NHANES III Follow-up // Brit. J. Haematol. — 2009. —Vol. 145. № 4. —P. 514–523.
Zakai N. A., Katz R., Hirsch C., et al. A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the Cardiovascular Health Study // Arch. Intern. Med. — 2005 –Vol.165, N19. — P. 2214–2220.
Culleton B. F., Manns B. J., Zhang J., et al. Impact of anemia on hospitalization and mortality in older adults / Blood — 2006. — Vol. 107, N10– P. 3841–3846.
Beutler E., Waalen J. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? // Blood– 2006 — Vol. 107, N5. — P. 1747–1750.
Stauder R., Thein S. L. Anemia in the elderly: clinical implications and new therapeutic concepts // Haematologica — 2014 — Vol. 99, N7. — P. 1127–1130.
Gaskell H, Derry S, Andrew Moore R et al. Prevalence of anaemia in older persons: systematic review // BMC Geriatr. — 2008 — Vol. 8:1https://doi. org/10.1186/1471–2318–8–1.
denElzen W. P. J., Gussekloo J. Anaemia in older person // Netherlands J. Med. — 2011. — Vol. 69. № 6. — P. 260–267.
Bach V., Schruckmayer G., Sam I. et al. Prevalence and possible causes of anemia in the elderly: a crosssectional analysis of a large European university hospital cohort // Clin. Interv. Aging — 2014, — Vol. 9. — P. 1187–1196.
Beerman I., Bhattacharya D., Zandi S. et al. Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion // Proc. Nat. Acad. Sci. USA. — 2010. — Vol. 107. — P. 5465–5470.
den Elzen W. P. J., Martin-Ruiz C., von Zglinicki T. Telomere length and anaemia in old age: results from the Newcastle 85-plus Study and the Leiden 85-plus Study // Age Ageing. —2011. —Vol. 40. № 4. —P. 494–500.
Burgstaller S., Wiesinger P., Stauder R. Myelodysplastic syndromes in the elderly: treatment options and personalized management // Drugs Aging. —2015 — Vol. 32. P. 891–905.
Lippi G., Franchini M., Guidi G. C. Determinants of anaemia in the very elderly: a major contribution from impaired renal function? // Blood Transf. — 2010. — Vol. 8. — P. 44–48.
Adamson J. W. Hyporesponsiveness to erythropoiesis stimulating agents in chronic kidney disease: the many faces of inflammation // Adv. ChronicKidneyDis. —2009. — Vol. 16. — P. 76–82.
Ershler W. B., Sheng S., McKelvey J. et al. Serum erythropoietin and aging: a longitudinal analysis // J. Amer. Geriatr. Soc. —2005. —Vol. 53. — P. 1360–1365.
Ausk K. J., Ioannou G. N. Is obesity associated with anemia of chronic disease? A population-based study // Obesity (Silver Spring). — 2008. —Vol. 16. —P. 2356–2361.
Bayne S., Jones M. E., Li H., Liu J. P. Potential roles for estrogen in regulation of telomerase activity in aging // Ann. NY Acad. Scienc. — 2007. —Vol. 114. —P. 48–55.
Ferrucci L., Maggio M., Longo D. L. Low testosterone levels and the risk of anemia in older men and women // Arch. Int. Med. —2006. — Vol. 166. № 13. — P. 1380–1388.
Artz AS, Thirman MJ. Unexplained anemia predominates despite an intensive evaluation in a racially diverse cohort of older adults from a referral anemia clinic // J. Gerontol. ABiol. Sci. Med. Sci. — 2011. — Vol. 66A, N8. — P. 925–932.
Bross M. N., Soch K., Smith-Knuppel T. Anemia in older persons // Amer. Fam. Physician. —2010. — Vol. 82, № 5. — P. 480–487.
Valent P., Orazi A., Steensma D. P. et al. Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions // Oncotarget — 2017– Vol. 8. — N43. — P. 73483–73500.
Bach V., Schruckmayer G., Sam I. et al. Prevalence and possible causes of anemia in the elderly: a crosssectional analysis of a large European university hospital cohort // Clin. Interv. Aging. — 2014. — Vol. 9. — P. 1187–1196.
Zakai N. A., French B., Arnold A. M., et al. Hemoglobin decline, function, and mortality in the elderly: the cardiovascular health study // Am. J. Hematol. — 2013. — Vol. 88, N1. — P. 5–9.
Joosten E., Detroyer E., Milisen K. Effect of anaemia on hand grip strength, walking speed, functionality and 1 year mortality in older hospitalized patients // BMC Geriatr. — 2016. — Vol. 16, N1. P. 153. https://doi.org/10.1186/s12877–016–0326-y.
Goodnough L. T, Schrier SL. Evaluation and management of anemia in the elderly // Am J Hematol. — 2014. — Vol. 89, N1. — P. 88–96.
Nairz M., Theurl I., Wolf D., Weiss G. Differential diagnosis and mechanisms of anemia of inflammation // Wien Med. Wochenschr. — 2016 — Vol.166. N13 — P. 411–423.
Fairweather-TaitS. J., Wawer A. A., Gillings R. et al. Iron status in the elderly // Mech Ageing Dev. — 2014 — Vol. 136–137, N100. — P. 22–28.
Wawer A. A., Jennings A., Fairwetter-Tait S. J. Iron status in the elderly: a review of recent evidence // Mechanism of Ageing and Development — 2018 — Vol.185 –P. 55–73.
Busti F, Campostrini N., Martinelli N., Girelli D. Iron deficiency in the elderly population, revisited in the hepcidin era // Front Pharmacol. — 2014 — Vol. 5 — P. 83. doi: 10.3389/fphar.2014.00083.
Krayenbuehl P. A., Battegay E., Breymann C. et al. Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration // Blood — 2011 — Vol. 118 — P. 3222– 3227.
Hsu H. S., Li C. I., Liu C. S. et al. Iron deficiency is associated with increased risk for cardiovascular disease and all-cause mortality in the elderly living in long-term care facilities. // Nutrition –2013– Vol. 29, N5. —P.737–43.
Morkedal B., Laugsand L. E., Romundstad P. R., Vatten L. J. Mortality from ischaemic heart disease: sexspecific effects of transferrin saturation, serum iron, and total iron binding capacity. The HUNT study // Eur. J. Cardiovasc. Prev. Rehabil. — 2011 — Vol.18 — P. 687–694.
Camaschella C., Nai A., Silvestri L. Iron metabolism and iron disorders revisited in the hepcidin era // Haematologica. — 2020. — Vol. 105://doi. org/10.3324/haematol.2019.232124
Yiannikourides A., Latunde-Dada G. O. A short review of iron metabolism and pathophysiology of iron disorders // Medicines (Basel). — 2019 — Vol. 6, N3 — Р. 85. doi: 10.3390/medicines6030085
Lopez A., Cacoub P., Macdaugall I. C., Peyrin-Biroulet L. Iron deficiency anaemia // Lancet– 2016 –Vol. 387 — P. 907–916.
Suchdev P. S., Williams A. M., Mei Z. et al. Assessment of iron status in settings of inflammation: challenges and potential approaches // Am. J. Clin. Nutr. — 2017 — Vol. 106. — P. 1626–1633.
Cappellini M. D., Comin-Colet J., de Francisco A. et al. Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management // Am. J. Hematol. — 2017– Vol. 92– P. 1068–1078.
Infusino I., Braga F., Dolci A., Panteghini M. Soluble transferrin receptor (sTfR) and sTfR/log ferritin index for the diagnosis of iron-deficiency anemia. A meta-analysis // Am J ClinPathol –2012– Vol. 138– P. 642–649.
Buttarello M. Laboratory diagnosis of anemia: are the old and new red cell parameters useful in classification and treatment, how? // International Journal of laboratory hematology. —2016 — Vol.38 — Issue S1https://doi. org/10.1111/ijlh.12500.
Karlsson T. Mass spectrometry evaluation of the hepcidin — 25 assay in the differential diagnosis of irondeficiency anaemia with concurrent inflammation and anaemia of inflammation in elderly patients // Eur. J. Haematol — 2015– Vol. 5 — P. 467–471.
Barron B. A., Hoyer J. D., Tefferi A. A bone marrow report of absent stainable iron is not diagnostic of irondeficiency // Ann. Hematol. — 2001. — Vol. 80–P. 166–169.
Lopez-Contreas M. J., Zamoro-Portero S, Lopez MA et al. Dietary and iron status of instutionalized elderly people: relationship with different factors // J. Nutr. Health Aging –2010 –Vol.10 — P. 816–821.
Annibale B., Capuro G., Chistolini A. et al. Gastrointestinal causes of refractory iron deficiency anemia in patients without gastrointestinal symptoms // Am. J. Med. — 2001 — Vol. 111– P. 439–445.
Goddard A. F, James M. W., McIntyre A. S., Scott B. B. Guidelines for the management of iron deficiency anemia // Gut– 2011 –Vol. 60. —P. 1309–1316.
Soon A., Cohen B. L., Groessl E. J., Ho S. B. Long-term outcomes and prognostic factors for patients with endoscopy-negative iron deficiency // Dig. Dis. Sci. —2013– Vol. 58 — P. 488–495.
Muhammad A., Vidyarthi G., Brady P. Role of small bowel capsule endoscopy in the diagnosis and management of iron deficiency anemia in the elderly: a comprehensive review of the current literature // World J. Gastroenterol . —2014. — Vol. 20 — P. 8416–8423.
Hershko C, Camaschella C. How I treat unexplained refractory iron-deficiency anemia // Blood –2014 — Vol. 123 — P. 326–333.
Pasricha S-R., Drakesmith H., Black J. et al. Control of iron deficiency anemia in low- and middle-income countries // Blood –2013 — Vol.121, N14 — P. 2607–2617.
Румянцев А. Г., Масчан А. А., Чернов В. М., Тарасова И. С. Федеральные клинические рекомендации по диагностике и лечению железодефицитной анемии. М.: 2015. 16 с.
Moretti D., Goede J. S., Zeder C. et al. Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice daily dosis in iron-depleted young women // Blood. — 2015. —Vol. 126. — P. 1981– 1989.
Auerbach M., Adamson J. W. How we diagnose and treat iron deficiency anaemia // Am. J. Hematol. — 2016 — Vol. 91. — P. 31–38.
Beyer I., Compte N., Busuioc A. et al. Anemia and transfusions in geriatric patients: a time for evaluation // Hematology. — 2010 — Vol. 15, N2. — P. 116–121.
ABIM Foundation. Choosing Wisely: lists — American Society of Hematology. http://www. choosingwisely. org/clinician-lists/american-society-hematology-red-blood-cell-transfusions-for-anemia / Accessed 22 September 2017
Weiss G., Ganz T., Goodnough L. T. Anemia of inflammation // Blood-2019– Vol. 133, N1. — P. 40–50.
Madu A. J., Ughasoro M. D. Anaemia of chronic disease: an in-depth review // Med. Princ. Pract. —2017. — Vol. 26, N1. — P. 1–9.
Рукавицын О. А. Анемия хронических заболеваний: отдельные аспекты патогенеза и пути коррекции // Онкогематология — 2016. — Т 11, № 1. — С. 37–46.
Muckenthaler M. U., Rivella S., Hentze M. W., Galy B. A red carpet for iron metabolism. Cell // 2017. — Vol.168, N3. — P. 344–361.
Latour C., Wlodarczyk M. F., Jung G., et al. Erythroferrone contributes to hepcidin repression in a mouse model of malarial anemia // Haematologica — 2017. — Vol. 102, N1. — P. 60–68.
Dallalio G., Means R. T. Jr. Effects of oxidative stress on human erythroid colony formation: modulation by gamma-interferon // J. Lab. Clin. Med. —2003. — Vol. 141, N6. — P. 395–400.
Libregts S. F., Gutierrez L., de Bruin A. M., et al. Chronic IFN-γ production in mice induces anemia by reducing erythrocyte life span and inhibiting erythropoiesis through an IRF-1/PU.1 axis // Blood. — 2011. — Vol.118, N9. — P. 2578–2588.
Gaspar B. L., Sharma P., Das R. Anemia in malignancies: pathogenetic and diagnostic considerations // Hematology. — 2015. — Vol. 20. — P. 18–25.
Camaschella C. Iron-deficiency anemia // N Engl J Med. — 2015. — Vol. 372. — P. 1832–1843.
Spivak J. L. Iron and the anemia of chronic disease // Oncology (Williston Park) — 2002. — Vol. 16. — P. 25–33.
Богданов А. Н., Волошин С. В., Кулибаба Т. Г. и др. Изменения системы крови в клинической практике. СПб: Фолиант, 2017: 172 с.
Joosten E. Iron deficiency anemia in older adults: a review // Geriatr. Gerontol. Int. — 2018. — Vol. 18. — P. 373–379.
Petzer V., Theurl I., Weiss G. Established and emerging concepts to treat imbalances of iron homeostasis in inflammatory diseases // Pharmaceuticals (Basel). —2018. Vol. 11. — P. 135.
Przybyszewska J., Zekanowska E., Kedziora-Kornatowska K., et al. Serum prohepcidin and other iron metabolism parameters in elderly patients with anemia of chronic disease and with iron deficiency anemia // Pol. Arch. Med. Wewn. —2013. — Vol. 123. — P. 105–111.
Cappellini M. D., Comin-Colet J., de Francisco A. et al. Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management // Am. J. Hematol. —2017– Vol.92– P. 1068–1078.
Румянцев А. Г., Масчан А. А. Федеральные клинические рекомендации по диагностике и лечению анемий хронических болезней. М., 2014. —9 с.
Шило В. Ю., Добронравов В. А., Земченков А. Ю. и др. Национальные рекомендации «Диагностика и лечение анемии при хронической болезни почек». М., 2014. — 35 с.
Docherty A. B., Turgeon A. F., Walsh T. S. Best practice in critical care: anaemia in acute and critical illness // Transfus. Med. — 2018. — Vol. 28, N2. — P. 181–189.
Casper C., Chaturvedi S., Munshi N. et al. Analysis of inflammatory and anemia-related biomarkers in a randomized, double-blind, placebo-controlled study of siltuximab (anti-IL6 monoclonal antibody) in patients with multicentricCastleman disease // Clin. Cancer Res. — 2015. — Vol. 21. — P. 4294–4304.
Katsarou A., Pantopoulos K. Hepcidin therapeutics // Pharmaceuticals (Basel). —2018. —Vol. 11, N4. — P. 127.
Nagao T., Hirokawa M. Diagnosis and treatment of macrocytic anemias in adults // J Gen Fam Med. — 2017. — Vol. 18, N5. — P. 200–204.
Socha D. S., DeSouza S. I., Flagg A. et al. Severe megaloblastic anemia: Vitamin deficiency and other causes // Cleveland Clinic Journal of Medicine– 2020 — Vol. 87, N3. — P. 153–164.
Aslinia F., Mazza J. J., Yale S. H. Megaloblastic anemia and other causes of macrocytosis // Clin. Med. Res. — 2006. — Vol. № 3. — P. 236–241.
Steensma D. P. Dysplasia has a differential diagnosis: distinguishing genuine myelodysplastic syndromes (MDS) from mimics, imitators, copycats and impostors // Curr. Hematol. Malig. Rep. — 2012. — Vol. 7, N4. — P. 310–320.
Savage D. G, Ogundipe A, Allen R. H. et al. Etiology and diagnostic evaluation of macrocytosis // Am. J. Med. Sci. — 2000. — Vol. 319. — P. 343–352.
Seppa K, Heinila K, Sillanaukee P, Saarni M. Evaluation of macrocytosis by general practitioners // J Stud Alcohol. —1996. — Vol. 57. — P. 97–100.
Mahmoud MY, Lugon M, Anderson CC. Unexplained macrocytosis in elderly patient // Age Ageing. —1996. —Vol. 25. — P. 310–312.
Green R., Datta Mitra A. Megaloblasticanemias: nutritional and other causes // Med. Clin. North Am. —2017. — Vol. 101, N2. — P. 297–317.
Wong C. W. Vitamin B12 deficiency in the elderly: is it worth screening? // Нong Kong Med. J. 2015. — Vol. 21, N2. — P. 155–164.
Rojas Hernandez C. M., OO TH Advances in mechanisms, diagnosis, and treatment of pernicious anemia // Discov. Med. — 2015 — Vol. 104. — P. 159–168.
Alpers D. H., Russell-Jones G. Gastric intrinsic factor: the gastric and small intestinal stages of cobalamin absorption. A personal journey // Biochimi. — 2013 — Vol. 95, N5. — P. 989–994.
Лукина Е. А. Цветаева Н. В., Двирнык В. Н. и др. В12-дефицитная анемия. Клинические рекомендации. М., 2020. — 28 с.
Neumann WL, Coss E, Rugge M, Genta RM. Autoimmune atrophic gastritis–pathogenesis, pathology and management // Nat Rev GastroenterolHepatol. — 2013. — Vol. 10. — P. 529–541.
Andres E., Goichot B., Schlienger J. L. Food-cobalamin malabsorption: a usual cause of vitamin B12 deficiency // Arch Intern Med. —2000. — Vol. 160. — P. 2061–2062
Stover P. J. Vitamin B12 and older adults // Curr. Opin. Clin. Nutr. Metab. Care. — 2010. — Vol. 13. — P. 24– 27.
denElzen W. P. J., van der Weele G. M., Gussekloo J. et al. Subnormal vitamin B12 concentrations and anaemia in older people: a systematic review//BMC Geriatr. —2010. —Vol. 10. —P. 42.
Oo T. H. Diagnostic difficulties in Pernicious Anemia // Discov. Med. — 2019. — Vol. 28. — P. 247–253.
Toh B-H. Pathophysiology and laboratory diagnosis of pernicious anemia // Immunol. Res. —2017. — Vol. 65. — P. 326–30.
Stabler S. P. Clinical practice. Vitamin B12 deficiency // N. Engl. J. Med. — 2013. — Vol. 368, N2. — P. 149– 160.
Воробьев А. И. Руководство по гематологии, «Ньюдиамед», М, 2005, т. 3, с. 198–210.
Лукина Е. А. Цветаева Н. В., Сысоева Е. П. и др. Фолиеводефицитная анемия. Клинические рекомендации. М., 2020. — 27 с.
Kaferle J, Strzoda CE. Evaluation of macrocytosis // Am Fam Physician. — 2009. — Vol.79. — P. 203–208.
Shargian-Alon L., Pazgal I., Raanani P., Rachmilewitz E. Thalassemia major and intermedia in older patients — a single center experience // Blood. — 2014. — Vol.124, N21. — P. 2685. https://doi. org/10.1182/blood. V124.21.2685.2685
Thein S. L., How I treat the older adult with sickle cell disease // Blood. — 2018 — Vol. 132, N17. — P. 1750–1760.
Hoffman PC. Immune hemolytic anemia — selected topics // Hematology Am. Soc. Hematol. Educ. Program. — 2009. — N. 1. — P. 80–86.
Roth S., Obrecht V., Putetto M. et al. Anemia in the elderly: experience in an acute geriatric unit and recommendations // Rev Med Intern. — 2009. — Vol.30. — S111.
Zulfiqar A-A., Pennaforte J-L., Andres E. Autoimmune hemolytic anemia in individuals aged 75 and older: a study of 10 individuals // J AmerGer Soc. — 2016. — Vol. 64, N6. — P. 1372–1374.
Zeerleder S. Autoimmune haemolyticanaemia — a practical guide to cope with diagnostic and theurapeutic challenge // Netherlands J. Med. — 2011. — Vol. 69. — P. 177–184.
Jager U., Barcellini W., Broome C. M. et alDiagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting // Blood Reviews. — 2020. — Vol.41. — P. 100648. https://doi. org/10.1016/j. blre.2019.
Contejean A., Resche-Rigon M., JeromeTamburini J. et al. Aplastic anemia in the elderly: a nationwide survey on behalf of the French Reference Center for Aplastic Anemia // Haematologica. — 2019 — Vol. 104, N2. — P. 256–262.
Young N. S., Kaufman D. W. The epidemiology of acquired aplastic anemia // Haematologica. — 2008. — P. 93, N4. — P. 489–492.
Montane E., Ibanez L., Vidal X., et al. Epidemiology of aplastic anemia: a prospective multicenter study // Haematologica. — 2008. — Vol. 93, N4. — P. 518–523.
Tichelli A., Rovo A., Marsh J. C. W. Congenital and Acquired Bone Marrow Failure. Chapter 12 — Treatment of Elderly Patients With Aplastic Anemia. — 2017. — P. 141–151.
Price E. A., Mehra R., Holmes T. H., Schrier S. L. Anemia in older persons: etiology and evaluation // Blood Cells Molec. Dis. —2011. —Vol. 46. —P. 159–165.

Еще

Статья научная